| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.098 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |